164 related articles for article (PubMed ID: 10517005)
1. Synthesis and pharmacological evaluation of 4-halo progesterone derivatives as antiandrogen.
Cabeza M; Quiroz A; Bratoeff E; Murillo ME; Ramírez E; Flores G
Chem Pharm Bull (Tokyo); 1999 Sep; 47(9):1232-6. PubMed ID: 10517005
[TBL] [Abstract][Full Text] [Related]
2. New progesterone esters as 5alpha-reductase inhibitors.
Cabeza M; Heuze I; Bratoeff E; Murillo E; Ramirez E; Lira A
Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1081-4. PubMed ID: 11558590
[TBL] [Abstract][Full Text] [Related]
3. Antiandrogenic effect of 16-substituted, non-substituted and D-homopregnane derivatives.
Bratoeff EA; Herrera H; Ramírez E; Solorzano K; Murillo E; Quiróz A; Cabeza M
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1249-55. PubMed ID: 10993221
[TBL] [Abstract][Full Text] [Related]
4. New aromatic esters of progesterone as antiandrogens.
Bratoeff E; Ramírez E; Flores E; Sánchez M; Heuze I; Cabeza M
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):99-105. PubMed ID: 15449723
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of new 16-methyl pregnane derivatives.
Ramirez E; Cabeza M; Heuze I; Gutiérrez E; Bratoeff E; Membrillo M; Lira A
Chem Pharm Bull (Tokyo); 2002 Jan; 50(1):15-20. PubMed ID: 11824579
[TBL] [Abstract][Full Text] [Related]
6. Androgenic and anti-androgenic effects of progesterone derivatives with different halogens as substituents at the C-6 position.
Cabeza M; Gutiérrez E; Miranda R; Heuze I; Bratoeff E; Flores G; Ramírez E
Steroids; 1999 Jun; 64(6):413-21. PubMed ID: 10433178
[TBL] [Abstract][Full Text] [Related]
7. 5 Alpha-reductase inhibitory and antiandrogenic activities of novel steroids in hamster seminal vesicles.
Cabeza M; Bratoeff E; Flores E; Ramírez E; Calleros J; Montes D; Quiroz A; Heuze I
Chem Pharm Bull (Tokyo); 2002 Nov; 50(11):1447-52. PubMed ID: 12419908
[TBL] [Abstract][Full Text] [Related]
8. Steroidal antiandrogens and 5alpha-reductase inhibitors.
Bratoeff E; Ramírez E; Murillo E; Flores G; Cabeza M
Curr Med Chem; 1999 Dec; 6(12):1107-23. PubMed ID: 10519917
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of new pregnane derivatives as 5alpha-reductase inhibitor.
Cabeza M; Heuze I; Bratoeff E; Ramírez E; Martínez R
Chem Pharm Bull (Tokyo); 2001 May; 49(5):525-30. PubMed ID: 11383600
[TBL] [Abstract][Full Text] [Related]
10. Molecular interactions of progesterone derivatives with 5 alpha-reductase types 1 and 2 and androgen receptors.
Bratoeff E; García P; Heuze Y; Soriano J; Mejía A; Labastida AM; Valencia N; Cabeza M
Steroids; 2010 Jul; 75(7):499-505. PubMed ID: 20359488
[TBL] [Abstract][Full Text] [Related]
11. Antiandrogen. III. 11-oxapregnane steroids.
Takegawa S; Koizumi N; Mieda M; Shibata K
Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):746-8. PubMed ID: 8681406
[TBL] [Abstract][Full Text] [Related]
12. Antiandrogen. I. 2-azapregnane and 2-oxapregnane steroids.
Shibata K; Takegawa S; Koizumi N; Yamakoshi N; Shimazawa E
Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):935-41. PubMed ID: 1381997
[TBL] [Abstract][Full Text] [Related]
13. Relative binding affinity of novel steroids to androgen receptors in hamster prostate.
Cabeza M; Heuze I; Sánchez M; Bratoeff E; Ramírez E; Rojas A; Orozco A; Mungía A; Agustín G; Cuatepotzo L; Gonzalez C; Palma S; Padilla D; Perez V; Jimenez G
J Enzyme Inhib Med Chem; 2005 Aug; 20(4):357-64. PubMed ID: 16206830
[TBL] [Abstract][Full Text] [Related]
14. Antiandrogenic effect of new synthetic steroids.
Cabeza M; Quiroz A; Heuze I; Bratoeff E; Herrera H; Ramírez E; Murillo E
Proc West Pharmacol Soc; 2000; 43():31-2. PubMed ID: 11056950
[TBL] [Abstract][Full Text] [Related]
15. Antiandrogen. II. Oxygenated 2-oxapregnane steroids.
Takegawa S; Koizumi N; Takahashi H; Shibata K
Chem Pharm Bull (Tokyo); 1993 May; 41(5):870-5. PubMed ID: 7687931
[TBL] [Abstract][Full Text] [Related]
16. The action of 5 alpha-dihydrotestosterone and antiandrogens on the activities of 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase in the pituitary gland of gonadectomized rats.
Ghraf R; Schneider K; Kirchhoff J; Hiemke C
J Steroid Biochem; 1982 Apr; 16(4):545-52. PubMed ID: 6806544
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5 alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Ramirez E; Heuze Y; Flores E
Curr Med Chem; 2005; 12(8):927-43. PubMed ID: 15853706
[TBL] [Abstract][Full Text] [Related]
18. In vivo assay for conversion of testosterone to dihydrotestosterone by rat prostatic steroid 5 alpha-reductase and comparison of two inhibitors.
Toomey RE; Goode RL; Petrow V; Neubauer BL
Prostate; 1991; 19(1):63-72. PubMed ID: 1876537
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological evaluation of new progesterone esters as 5alpha-reductase inhibitors.
Ramírez E; Cabeza M; Bratoeff E; Heuze I; Pérez V; Valdez D; Ochoa M; Teran N; Jimenez G; Ramírez T
Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1515-8. PubMed ID: 16327180
[TBL] [Abstract][Full Text] [Related]
20. Prostate. III--A structural feature characteristic of the rat prostate 5 alpha-reductase active site.
Petrow V; Padilla GM; McPhail AT; Bruchovsky N; Schneider SL
J Steroid Biochem; 1989 Mar; 32(3):399-407. PubMed ID: 2704237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
